Translation and cross-cultural validation of the French version of the Sleep-Related Breathing Disorder scale of the Pediatric Sleep Questionnaire.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
06 2019
Historique:
received: 25 12 2018
revised: 18 02 2019
accepted: 19 02 2019
pubmed: 31 5 2019
medline: 15 7 2020
entrez: 31 5 2019
Statut: ppublish

Résumé

Sleep-disordered breathing (SDB), including obstructive sleep apnea syndrome, is often underestimated because it requires a burdensome test (ie, polysomnography) to ensure diagnosis. To improve polysomnography referral, it is of utmost importance to validate efficient alternative screening tools. This study aimed to provide a translation and a cross-cultural validation of the Pediatric Sleep Questionnaire (PSQ) into French to obtain an easy-to-use and reliable screening tool. The psychometric properties of the French version were also determined. The process of cross-cultural adaptation was carried out following these steps: forward-backward translation, evaluation by an expert committee, and pretesting of the pre-final version. Reliability of the French-PSQ version was assessed by Cronbach's alpha coefficients and Spearman's correlation on a convenient sample of 201 children (aged between 2 and 17 years). Construct validity was determined by factor analysis of principal components. Internal consistency was within an adequate range for all subscales: 0.711 for snoring, 0.559 for sleepiness, 0.682 for behavioral problems, and 0.776 for the whole questionnaire. Spearman's correlation analysis comparing questionnaires administered two weeks apart showed good correlation coefficients for all subscales (snoring: 0.642, sleepiness: 0.846, behavioral problems: 0.780, and entire SRBD scale: 0.835). Factor analysis performed to assess the structure of the French-SRBD scale confirmed the same four factors described in the original questionnaire ("breathing," "behavior," "sleepiness," and "other"). The French version of the PSQ has been successfully cross-culturally adapted and showed good psychometric properties, suggesting that it is useful as a tool to screen sleep-disordered breathing in French-speaking children.

Sections du résumé

BACKGROUND
Sleep-disordered breathing (SDB), including obstructive sleep apnea syndrome, is often underestimated because it requires a burdensome test (ie, polysomnography) to ensure diagnosis. To improve polysomnography referral, it is of utmost importance to validate efficient alternative screening tools. This study aimed to provide a translation and a cross-cultural validation of the Pediatric Sleep Questionnaire (PSQ) into French to obtain an easy-to-use and reliable screening tool. The psychometric properties of the French version were also determined.
METHODS
The process of cross-cultural adaptation was carried out following these steps: forward-backward translation, evaluation by an expert committee, and pretesting of the pre-final version. Reliability of the French-PSQ version was assessed by Cronbach's alpha coefficients and Spearman's correlation on a convenient sample of 201 children (aged between 2 and 17 years). Construct validity was determined by factor analysis of principal components.
RESULTS
Internal consistency was within an adequate range for all subscales: 0.711 for snoring, 0.559 for sleepiness, 0.682 for behavioral problems, and 0.776 for the whole questionnaire. Spearman's correlation analysis comparing questionnaires administered two weeks apart showed good correlation coefficients for all subscales (snoring: 0.642, sleepiness: 0.846, behavioral problems: 0.780, and entire SRBD scale: 0.835). Factor analysis performed to assess the structure of the French-SRBD scale confirmed the same four factors described in the original questionnaire ("breathing," "behavior," "sleepiness," and "other").
CONCLUSION
The French version of the PSQ has been successfully cross-culturally adapted and showed good psychometric properties, suggesting that it is useful as a tool to screen sleep-disordered breathing in French-speaking children.

Identifiants

pubmed: 31146124
pii: S1389-9457(19)30061-9
doi: 10.1016/j.sleep.2019.02.021
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-129

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Laurence Jordan (L)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France; Structural Metallurgy Unit, IRCP UMR 8247, Chimie ParisTech, Paris, France. Electronic address: laurence.jordan@univ-paris-diderot.fr.

Nicole Beydon (N)

Department of Functional Respiratory Exploration and Sleep Center, Armand Trousseau Hospital, Paris, France.

Noéline Razanamihaja (N)

Paris Diderot University, Sorbonne Paris Cité, Paris, France.

Pascal Garrec (P)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France.

Maria Clotilde Carra (MC)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Department of Periodontology, Rothschild Hospital and Population-based Epidemiologic Cohorts Unit, UMS 011, Villejuif, France.

Benjamin P Fournier (BP)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France; Molecular Oral Pathophysiology, Cordeliers Center Recherche, UMR S1163, Paris, France.

Brigitte Vi-Fane (B)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France.

Stéphane Kerner (S)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France.

Rufino Felizardo (R)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France.

Marie-Laure Boy-Lefèvre (ML)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France.

Muriel De La Dure-Molla (M)

Paris Diderot University, Sorbonne Paris Cité, Paris, France; Reference Center for Oral and Dental Rare Diseases, Rothschild Hospital, AP-HP, Paris, France; Molecular and Physiopathological Bases of Osteochondrodysplasia, Imagine Institute, UMR-S1163, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH